FDA
-
-
-
-
-
-
-
Hepion Pharmaceuticals (HEPA) Prices $9M Offering
-
-
-
-
-
-
-
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
-
-
-
-
-
-
-
Hepion Pharmaceuticals to Present at NASH-TAG 2024
-
-
-
-
-
-
-
Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
-
-
-
-
-
-
-
New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening Program
-
-
-
-
-
-
-
Hepion Pharmaceuticals to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
-
-
-
-
-
-
-
Hepion Pharmaceuticals Expands SAB with Appointments of Four Liver Disease KOLs
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

